PureHealth’s Global Gambit Pays Off as Foreign Assets Drive Profit Surge

ABU DHABI, UAE – July 31, 2026 – PureHealth Holding PJSC has delivered a powerful demonstration of its global expansion strategy, reporting a 20% year-on-year surge in net profit to USD 337 million for the first half of 2026. The Middle East’s largest healthcare group saw its revenue climb 9% to USD 4.0 billion, a performance heavily underwritten by its rapidly growing international portfolio.

The results underscore a strategic pivot that is reshaping the ambitions of regional champions. Once focused primarily on domestic markets, PureHealth is now a case study in leveraging a strong local foundation to build a diversified global enterprise. International operations, primarily in Europe, now account for a full third of the Group's revenue, showcasing the success of recent high-profile acquisitions.

"PureHealth's performance in the first half of 2026 reflects the strength of our long-term strategy and the disciplined execution of our vision to build a globally diversified healthcare group," said H.E. Kamal Al Maazmi, Chairman of PureHealth. He emphasized a focus on diversifying the earnings base and reinforcing foundations for sustainable long-term growth, a clear signal of the Group's global outlook.

The Engine of International Expansion

The most telling figures in PureHealth’s H1 results come from beyond its home borders. The international 'Care' division saw revenue skyrocket by 56% year-on-year to USD 1.3 billion. More significantly, EBITDA from these foreign operations jumped 65% to USD 300 million, with margins expanding to a robust 22.2%. This confirms the thesis that these international assets are not just adding scale, but are highly accretive to the bottom line.

The primary driver of this growth is the successful consolidation of the Hellenic Healthcare Group (HHG), the largest private healthcare provider in Greece and Cyprus, which PureHealth acquired a majority stake in last year. HHG has maintained strong momentum, with patient volumes increasing 6% on the back of outpatient growth. The integration is also deepening, with HHG beginning to roll out PureNet, PureHealth’s proprietary healthcare cloud, a key step in creating a unified digital ecosystem.

Meanwhile, in the United Kingdom, Circle Health Group—the country's largest private hospital network—continued its solid performance with a 6.3% revenue increase. This growth is supported by a strategic shift towards higher-acuity, more complex inpatient procedures. The persistent long waiting lists within the UK's National Health Service (NHS) have created a sustained tailwind, driving more patients toward self-funded care and private insurance, a market dynamic Circle Health is well-positioned to capitalize on. The Group's global reach is further extended by its minority stake in Ardent Health Services, the fourth-largest private hospital operator in the U.S., which continues to expand its own footprint.

Anchoring Excellence in the UAE

While its global ambitions capture headlines, PureHealth has not neglected its foundational market. The Group's domestic operations remain a pillar of stability and growth, with the UAE 'Care' vertical posting USD 1.6 billion in revenue. Patient activity across its local network strengthened significantly, with outpatient volumes rising 7% and inpatient volumes growing 10%. This heightened demand pushed bed occupancy across its UAE hospitals to a healthy 75%.

This domestic strength is being reinforced by significant capital investment. The company recently broke ground on the SEHA New Corniche Hospital for Women and Newborns, a landmark 108,000-square-metre facility in Abu Dhabi. This 357-bed hospital is a cornerstone of a new specialized medical city, demonstrating a long-term commitment to enhancing the UAE's healthcare infrastructure.

Furthermore, the Group is moving beyond the hospital walls. A strategic partnership with Aldar Properties, one of the UAE's largest real estate developers, aims to integrate preventive wellness and longevity-focused living into future residential communities. This signals a strategic evolution from treating sickness to proactively managing health at a population level.

The 'Cover' or insurance vertical, anchored by Daman, also showed resilient growth, with revenue up 10% to USD 1.1 billion and the number of insured members growing to 3.4 million. In a major vote of confidence, Daman was assigned an A1 Insurance Financial Strength Rating by Moody's—the highest ever given to a UAE insurer—cementing its status as a market leader with a resilient business model.

A Revolution in Care Through Technology and Specialization

Beyond the impressive financial metrics, PureHealth is executing a quiet revolution in clinical capability, powered by technology and a deep focus on specialized medicine. Nothing showcases this more vividly than the recent successful separation of craniopagus twins in Abu Dhabi, a first for the GCC region. The incredibly complex procedure involved over 60 professionals and relied on a suite of advanced technologies, including augmented reality simulations, virtual reality collaboration, 3D printing, and AI-enhanced surgical planning.

This commitment to innovation is being institutionalized across the Group. The newly launched Abu Dhabi Health Research Centre (ADHRC) now consolidates all research activities, with a mandate to leverage AI and machine learning to process vast datasets, predict health trends, and identify new therapeutic targets. The center is already supporting over 100 active clinical studies.

"We continued to invest in advanced clinical capabilities, digital front door of PURA, AI-enabled technologies and capacity expansion across our ecosystem," commented Shaista Asif, Group Chief Executive Officer of PureHealth. "These investments are strengthening the quality of services we provide today while positioning PureHealth for its next phase of growth."

This investment is tangible across the network. Circle Health in the UK has deployed a second 'Da Vinci 5' robotic surgical system and completed the world's first AutoPlan-enabled total knee arthroplasty. In the UAE, SEHA became the first provider to offer histotripsy, a non-invasive treatment for liver tumors. The Group has also launched SAKINA for Children, a dedicated mental health network to address a critical service gap for young people.

With a confident outlook, PureHealth has reaffirmed its medium-term targets. The strategy is clear: leverage a diversified, multi-market platform to drive sustainable growth. The successful integration of its international assets, combined with relentless investment in technology and local infrastructure, provides multiple engines for expansion. As these recent acquisitions mature and operational synergies deepen, the Abu Dhabi-based firm is not just building a healthcare empire, but also crafting a new model for how regional leaders can project influence and innovation on a global scale.